Parkinson's Disease Drugs Pipeline 2023: ... - Cure Parkinson's

Cure Parkinson's

26,509 members27,921 posts

Parkinson's Disease Drugs Pipeline 2023: Clinical Trials, Latest breakthroughs, Treatment Market, Therapies

0 Replies

marketwatch.com/press-relea...

Apr 06, 2023 (AB Digital via COMTEX) -- (New York, USA) DelveInsight’s, “Parkinson’s Disease Pipeline Insight, 2023” report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Parkinson’s Disease pipeline landscape. It covers the pipeline drug profiles, including Parkinson’s Disease clinical trial and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key takeaways from the Parkinson’s Disease Pipeline Insight Report

DelveInsight’s Parkinson’s disease pipeline report depicts a robust space with 140+ active players working to develop 150+ pipeline therapies for Parkinson’s Disease treatment.

The leading Parkinson’s Disease Companies include Cerevel Therapeutics, Abbvie, Pharma Two B, Roche, Kissei Pharmaceutical, Peptron, Inc., Lundbeck A/S, AstraZeneca, Nobilis Therapeutics, Treefrog Therapeutics, Cantabio Pharmaceuticals, Anavex Life Sciences, Ipsen, Prevail Therapeutics, AFFiRiS, Sio Gene Therapies, UCB Pharma, Brain Neurotherapy Bio, Inc., Neuraly, Inc., NeuroDerm, BlueRock Therapeutics, Sun Pharma Advanced Research Company, Xoc Pharmaceuticals, Hong Kong WD Pharmaceutical, 1ST Biotherapeutics, Inc., Biogen, Denali Therapeutics, Inhibikase Therapeutics,Cerevance, Aspen Neuroscience,Prilenia Therapeutics,Cortexyme Inc.,Gain Therapeutics, Clexio Biosciences, Orpheris, Inc., Alkahest, Inc, and others.

Promising Parkinson’s Disease Drugs Pipeline in various stages of development include Rotigotine, extended-release microspheres, LY03003, LY3884961, Methylprednisolone, Sirolimus, VY-AADC02, ERE-120: AAV2-NTN, Liatermin, MEDI1341, and others.

The Parkinson’s Disease Companies and academics that are working to assess challenges and seek opportunities that could influence Parkinson’s disease R&D. The Parkinson’s Disease pipeline therapies under development are focused on novel approaches to treat/improve the disease condition.

Read more about...

Not what you're looking for?

You may also like...

Big Pharma conspiracy theory

Is it true that the pharmaceutical companies are hurdle in discovery of cure for PD. Some skeptics...
Farooqji profile image

PD tremor started on my non-dominant side yesterday

Parkinson’s disease is relentless I knew that but I thought I’d have good use of my left hand for...
BUZZ1397 profile image

Promising news from Australia for a breakthrough treatment for Parkinson's disease

The New Daily There’s quiet but confident hope for a breakthrough treatment for Parkinson’s...

Three distinct brain circuits in the thalamus contribute to Parkinson’s symptoms

Targeting these circuits could offer a new way to reverse motor dysfunction and depression in...

Results of Mannitol Repository from Clinicrowd

Dear Friends, some of you were very helpful in filling up the repository about the effect of...
Ranico profile image

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.